| Followers | 141 |
| Posts | 5785 |
| Boards Moderated | 0 |
| Alias Born | 06/09/2020 |
Monday, May 10, 2021 11:08:43 AM
God knows how long Bruce and Tamara has worked on uplisting now. It takes usually 4-6 weeks. According to VikingInvest:
"... if qualifying to list only under the Market Value Stand", meaning that if all the other requirements are not satisfied, a company can use this qualification requirement to list if they have been above $4 for 90 days. We easily qualify under the other requirements, so the 90 day rule shouldn't be applicable to us."
I am not competent to know, but whatever the market NWBO is gonna uplist to, and whatever the price. That'll be passed with ease, and the whole R/S discussion can be put six feet under.
LP is clearly intent on timing a s...load of catalysts within a very short timeframe. I predict TLD, uplisting, publication and an ASCO appearance. Followed by news regarding approval / BLA progression.
I do not believe LP or the rest of "the board" has intentions on "going alone". LP has intentions of squeezing BP for a premium price and to get within that, she will need to get the SP up.
It will not be a question, whether BP is hungry for DCVax-L and DCVax-Direct coming down the road. It is a question, WHEN BP are AL DENTE and can not afford to wait anymore.
When the news has sunk in, that DCVax-L becomes SOC, it will be a matter of time before the premium and the cherry on top, will be served.
And in the background you will be able to hear an almost an indistinct yelling by two faint figures. "But ... the warrants? And the patents? And the control arm? And the management?"
They almost seem cute!
"... if qualifying to list only under the Market Value Stand", meaning that if all the other requirements are not satisfied, a company can use this qualification requirement to list if they have been above $4 for 90 days. We easily qualify under the other requirements, so the 90 day rule shouldn't be applicable to us."
I am not competent to know, but whatever the market NWBO is gonna uplist to, and whatever the price. That'll be passed with ease, and the whole R/S discussion can be put six feet under.
LP is clearly intent on timing a s...load of catalysts within a very short timeframe. I predict TLD, uplisting, publication and an ASCO appearance. Followed by news regarding approval / BLA progression.
I do not believe LP or the rest of "the board" has intentions on "going alone". LP has intentions of squeezing BP for a premium price and to get within that, she will need to get the SP up.
It will not be a question, whether BP is hungry for DCVax-L and DCVax-Direct coming down the road. It is a question, WHEN BP are AL DENTE and can not afford to wait anymore.
When the news has sunk in, that DCVax-L becomes SOC, it will be a matter of time before the premium and the cherry on top, will be served.
And in the background you will be able to hear an almost an indistinct yelling by two faint figures. "But ... the warrants? And the patents? And the control arm? And the management?"
They almost seem cute!
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
